The Three-Quarter-Million Dollar Hope: Unpacking the Price of a Life-Saving SMA Drug
Spinal Muscular Atrophy (SMA), a devastating genetic disease, saw its first glimmer of hope with the drug Spinraza. But this life-altering treatment came with a staggering price: $750,000 for the first year, sparking a fierce global debate on drug pricing.